| Filed On | Filing |
|---|---|
| 29 Jun 2026 |
Form 3: Miyara Faical, Chief Business Officer
No securities owned |
| 21 Apr 2026 |
Form 3: Misra Veet, Chief Financial Officer
No securities owned |
| 10 Apr 2026 | Form 3: Cao Jin, Chief Accounting Officer |
| 23 Mar 2026 |
Form 3: Wang Shaomeng, Director
Holds 1,193,032 shares of Ordinary Shares |
| 23 Mar 2026 |
Form 3: Knapp Thomas J, SVP/General Counsel
Holds 362,444 shares of Ordinary Shares |
| 23 Mar 2026 |
Form 3: Zhai Yifan, Chief Medical Officer
Holds 1,097,994 shares of Ordinary Shares |
| 23 Mar 2026 |
Form 3: Wei Ren, Director
Holds 8,964 shares of Ordinary Shares |
| 19 Mar 2026 | Form 3: Ye Changqing, Director |
| 19 Mar 2026 | Form 3: Bozilenko Marina, Director |
| 19 Mar 2026 |
Form 3: Yang Dajun, Director
Holds 1,097,994 shares of Ordinary Shares |
| 19 Mar 2026 | Form 3: Sidransky David, Director |
| 19 Mar 2026 | Form 3: Lu Simon Dazhong, Director |
| 19 Mar 2026 |
Form 3: Lippman Marc E, Director
Holds 21,174 shares of Ordinary Shares |
| 19 Mar 2026 | Form 3: Yu Debra, Director |
Loading...